vinpocetine has been researched along with Autism Spectrum Disorder in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP | 2 |
| Ahring, P; Chebib, M; Gardella, E; Gjerulfsen, CE; Johannesen, KM; Liao, VWY; Mieszczanek, TS; Møller, RS; Nørby, HAJ; Rubboli, G | 1 |
3 other study(ies) available for vinpocetine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress.
Topics: Animals; Autism Spectrum Disorder; Biomarkers; Brain-Derived Neurotrophic Factor; Inflammation; Interleukin-10; Interleukin-6; Oxidative Stress; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2022 |
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.
Topics: Autism Spectrum Disorder; Epilepsy; Humans; Quality of Life; Receptors, GABA-A; Vinca Alkaloids | 2023 |
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
Topics: Animals; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Disease Models, Animal; Doublecortin Protein; Female; Inflammation; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Valproic Acid; Vinca Alkaloids | 2021 |